tDCS and Physical Therapy in Stroke
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00542256 |
Recruitment Status
:
Completed
First Posted
: October 11, 2007
Last Update Posted
: March 21, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
The purpose of this study is to determine whether a painless and noninvasive procedure called transcranial direct current stimulation (tDCS) combined with a method of physical therapy called constraint-induced movement therapy improves motor function in patients with chronic stroke. Research in healthy subjects has shown that when tDCS is combined with motor learning tasks, there is an increase in learning as compared to motor learning tasks only. The tDCS procedure sessions will be compared to sham (fake) procedure sessions, which is also called placebo stimulation. This study is double blind, which means neither the subjects nor researchers analyzing motor function will know if participants are receiving real tDCS stimulation or placebo. Only the person performing the procedure will know which one participants are receiving. Only by comparing the tDCS procedure to a sham (placebo) procedure can we understand if the tDCS actually improves motor function.
We hypothesize that tDCS will enhance the effects of constraint-induced movement therapy on motor recovery in chronic stroke patients.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Cerebrovascular Accident | Device: Active transcranial Direct Current Stimulation / Constraint Induced Movement Therapy Device: Sham transcranial Direct Current Stimulation / Constraint Induced Movement Therapy | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 85 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double (Participant, Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | Effects of Transcranial DC Stimulation Coupled With Constraint Induced Movement Therapy on Motor Function in Stroke Patients |
Study Start Date : | September 2007 |
Actual Primary Completion Date : | November 10, 2014 |
Actual Study Completion Date : | November 10, 2014 |
Arm | Intervention/treatment |
---|---|
Active Comparator: 1
Each subject will receive 14 days (2 week period: 10 weekdays and 2 weekends) of constraint induced movement therapy. In addition, on the 10 weekdays during the treatment period, the subjects will come into the laboratory and receive up to 6 hours per day of training of the affected arm in a variety of tasks. At the beginning of each of the 10 weekday training sessions, participants will receive 40 minutes of active tDCS over the primary motor cortex.
|
Device: Active transcranial Direct Current Stimulation / Constraint Induced Movement Therapy
14 days of constraint induced movement therapy with 10 weekdays of up to 6 hours of training of the affected arm combined with application of tDCS over the primary motor cortex for 40 minutes.
|
Sham Comparator: 2
Each subject will receive 14 days (2 week period: 10 weekdays and 2 weekends) of constraint induced movement therapy. In addition, on the 10 weekdays during the treatment period, the subjects will come into the laboratory and receive up to 6 hours per day of training of the affected arm in a variety of tasks. At the beginning of each training day tDCS will be applied for 40 minutes with the current active for only 30 seconds over the primary motor cortex.
|
Device: Sham transcranial Direct Current Stimulation / Constraint Induced Movement Therapy
14 days of constraint induced movement therapy with 10 days of up to 6 hours of training in the affected arm and sham tDCS applied over the primary motor cortex for 40 minutes with active current applied for 30 seconds.
|
- Jebsen-Taylor Hand Function Test [ Time Frame: Baseline, Treatment days 1,5,10, Follow Up ]
- Motor Activity Log Rating Scale [ Time Frame: Baseline, Treatment Days 1,5,10 and Follow Up ]
- Beck Depression Inventory [ Time Frame: Baseline, Treatment days 1,5,10 and Follow up ]
- Visual Analogue Scale for Anxiety [ Time Frame: Baseline, Treatment days 1,5,10 and Follow Up ]
- Fugl Meyer Assessment of Motor Recovery [ Time Frame: Baseline Assessment ]
- Barthel Index Score [ Time Frame: Baseline Assessment ]
- Modified Ashworth Scale [ Time Frame: Baseline Assessment ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 80 Years (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- First time clinical ischemic or hemorrhagic cerebrovascular accident (radiologically confirmed)
- Demonstrates adequate balance while wearing a hand restraint on the unaffected arm
- Ability to stand from a sitting position and ability to stand with or without upper extremity support
- Stroke onset at least 6 months prior to study enrollment
Exclusion Criteria:
- Significant pre-stroke disability
- Any substantial decrease in alertness, language reception, or attention that might interfere with understanding instructions for motor testing
- Excessive pain in any joint of the paretic extremity
- A terminal medical diagnosis consistent with survival of less than 1 year
- Advanced liver, kidney, cardiac, or pulmonary disease
- Coexistent major neurological or psychiatric disease (including epilepsy)
- A history of significant alcohol or drug abuse in the prior 3 years
- Use of neuropsychotropic drugs - such as antidepressants
- Patients may not be actively enrolled in a separate intervention study targeting stroke recovery
- Patients may not have already received constraint-induced movement therapy and/or tDCS treatment for stroke

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00542256
United States, Massachusetts | |
Beth Israel Deaconess Medical Center | |
Boston, Massachusetts, United States, 02215 |
Principal Investigator: | Felipe Fregni, MD, PhD | Beth Israel Deaconess Medical Center |
Additional Information:
Responsible Party: | Felipe Fregni, Study Principal Investigator, Beth Israel Deaconess Medical Center |
ClinicalTrials.gov Identifier: | NCT00542256 History of Changes |
Other Study ID Numbers: |
2007P000420 |
First Posted: | October 11, 2007 Key Record Dates |
Last Update Posted: | March 21, 2017 |
Last Verified: | March 2017 |
Studies a U.S. FDA-regulated Drug Product: | No | |
Studies a U.S. FDA-regulated Device Product: | No |
Keywords provided by Felipe Fregni, Beth Israel Deaconess Medical Center:
Apoplexy Cerebral Stroke Cerebrovascular Accident, Acute Cerebrovascular Apoplexy Cerebrovascular Stroke |
CVA (Cerebrovascular Accident) Stroke Stroke, Acute Vascular Accident, Brain |
Additional relevant MeSH terms:
Stroke Cerebrovascular Disorders Brain Diseases Central Nervous System Diseases |
Nervous System Diseases Vascular Diseases Cardiovascular Diseases |